Update on Venous Thromboembolism in Orthopaedic Trauma Surgery.

J Am Acad Orthop Surg · Oct 01 2024 · Review

Wills JH, Gaski GE

From the Department of Orthopedic Surgery, Medstar Georgetown University Hospital, Washington D.C, VA (Wills and Gaski)

Orthopaedic Trauma

SUMMARY — THE REDUCTIONRecent evidence shows aspirin noninferior to anticoagulants for VTE prevention in orthopaedic trauma; direct oral anticoagulants offer promising alternatives.
Abstract, as published

Venous thromboembolism (VTE) is a notable contributor to the morbidity and mortality of patients with orthopaedic trauma. Several associations have published guidelines on VTE prophylaxis, with a strong predilection toward low-molecular-weight heparin for chemoprophylaxis. However, previous recommendations may be revisited because recent high-level evidence demonstrated aspirin to be noninferior to low-molecular-weight heparin in preventing serious complications of VTE. Direct oral anticoagulants are emerging as safe alternatives to injectable medication and may offer improved patient compliance. There is no consensus on postinjury duration of chemoprophylaxis as an outpatient. Mechanical prophylaxis remains an important adjunctive VTE preventive measure for inpatients with pelvis and extremity fractures. Proteomics and novel laboratory measurements may be able to predict high-risk patients and detect early thrombus formation. Despite high-quality prospective research over the past decade, we still have much to learn about patient- and injury-specific risk factors.

Featured in the 2026-07-13 issue.

← Management of Lisfranc Injuries: A Critical Analysis Review.Management of Elbow Terrible Triad Injuries: A Comprehensive … →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.